Clinical Trials Browser

Phase 1/2 × Multiple Myeloma × durvalumab × Clear all

NCT02685826 2023-10-06

A Study of Durvalumab in Combination With Lenalidomide With and Without Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma

Phase 1/2 Completed

56 enrolled 38 charts

Multiple Myeloma